Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
HBKU-OVPR-SIC-01-18: Medical Large Language Models and Multi-Modal AI in Diabetes
Ismail, S. I. A. (Principal Investigator), Al Ejeh, F. H. S. (Principal Investigator) & Wang, C.-Y. (Lead Principal Investigator)
3/09/26 → 2/09/28
Project: Applied Research
-
HBKU-OVPR-SIC-01-19: Circulating Tumor Cell (CTC) Microfluids Liquid Biopsy Technology
Ismail, S. I. A. (Principal Investigator), Alajez, N. (Principal Investigator) & Al Ejeh, F. H. S. (Lead Principal Investigator)
3/09/26 → 2/09/28
Project: Applied Research
-
QBRI-CORE-000023: From Molecular Profiling to Diagnostics and Drug Targets: Integration for Precision Medicine in Breast Cancer
Al Ejeh, F. H. S. (Lead Principal Investigator), Jeya, S. S. P. (Post Doctoral Fellow) & Mestiri, S. (Research Associate)
1/01/26 → 31/12/28
Project: Experimental Development/Translation Research
-
EX-QNRF-ARG-131: From multi-omics to precision oncology and biological understanding of triple negative breast cancer
Abdesselem, H. B. (Principal Investigator), Ouararhni, K. (Principal Investigator), Al Ejeh, F. H. S. (Lead Principal Investigator), Jeya, S. S. P. (Post Doctoral Fellow), Mestiri, S. (Research Associate) & Murikkinthara Samuel, T. (Research Assistant)
15/07/25 → 15/07/28
Project: Experimental Development/Translation Research
-
QBRI-CORE-000005: From Molecular Profiling to Diagnostics and Drug Targets: Integration for Precision Medicine in Breast Cancer
Al Ejeh, F. H. S. (Lead Principal Investigator), Jeya, S. S. P. (Post Doctoral Fellow), Afifi, D. N. (Principal Investigator) & Mestiri, S. (Research Associate)
1/01/23 → 31/12/25
Project: Experimental Development/Translation Research
-
Emerging precision medicine in multiple myeloma: clinical and preclinical landscape of T cell, natural killer cell, and macrophages engaging multi-specific antibodies
Mestiri, S., Assami, L., Yoosuf, Z. S. K. M., Fernandes, Q., Abo El-Ella, D. M., Elsabah, H., Merhi, M., Makni-Maalej, K., Cherif, H., Dermime, S., Uddin, S. & Al-Ejeh, F., 7 Jul 2026, In: Frontiers in Immunology. 17, 32 p., 1822508.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer
Xue, M., Jeya, S., Elasad, R., Mestiri, S., Al Ejeh, F. & Al-Muftah, M., May 2026, In: Cancers. 18, 10, 1606.Research output: Contribution to journal › Article › peer-review
Open Access -
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation
Offenhäuser, C., Dave, K. A., Beckett, K. J., Smith, F. M., Jayakody, B. A., Cooper, L. T., Agyei-Yeboah, H., McCarron, J. K., Li, Y., Bastick, K., Al-Ejeh, F., Cullen, J. K., Coulthard, M. G., Gorman, J. J., Boyd, A. W. & Day, B. W., 10 Feb 2025, In: Oncogene. 44, 4, p. 208-227 20 p., 107568.Research output: Contribution to journal › Article › peer-review
Open Access13 Link opens in a new tab Citations (Scopus) -
METHODS OF TREATING SARS-COV-2 INFECTIONS
Al-Ejeh, F. H. (Inventor), Mohamed-Ali, V. (Inventor) & Al-Nesf, M. A. Y. (Inventor), 21 Mar 2024, IPC No. G01N 33/ 68 A I, Patent No. US2024094217, Priority date 25 Nov 2021, Priority No. US202118038665Research output: Patent
-
Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis
Al-Muftah, M. & Al-Ejeh, F., 1 Dec 2023, In: Cancer Epidemiology Biomarkers and Prevention. 32, 12, p. 1738-1746 9 p.Research output: Contribution to journal › Article › peer-review
21 Link opens in a new tab Citations (Scopus)